LHRH Agonist Treatment of Endometriosis

Endometriosis is a common disease in women during the reproductive ages. Estimates of the frequency of endometriosis range from 3% to 20% of the white female population and it is certainly the most prominent gynecological entity after uterine fibroids. Present therapeutic modalities for endometriosis include conservative surgery or ovarian suppression with hormones. The use of medical treatments is directed towards achieving ovarian suppression to avoid the steroidal stimulation of ectopic endometrial tissues. Preview Unable to display preview. Download preview PDF. Similar content being viewed by others Author information Authors and Affiliations Editor information Editors and Affiliations Rights and permissions Copyright information © 1990 Springer Science+Business Media Dordrecht About this chapter Cite this chapter Conti, A. (1990). LHRH Agonist Treatment of Endometriosis. In: Vickery, B.H., Lunenfeld, B. (eds) GnRH Analogues in Cancer and Human Reproduction. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2169-6_4 Download citation DOI: https://doi.org/10.1007/978-94-009-2169-6_4 Publisher Name: Springer, Dordrecht Print ISBN: 978-94-010-7474-2 Online ISBN: 978-94-009-2169-6 eBook Packages: Springer Book Archive

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.